tldrdailynews.com logo
Tag

Pharmaceuticals

All articles tagged with #pharmaceuticals

Iran War Broadens Global Supply-Chain Shocks Beyond Oil
business21 days ago

Iran War Broadens Global Supply-Chain Shocks Beyond Oil

The Iran conflict is disrupting far more than oil: helium supplies are tightening due to LNG-linked production in Qatar, with prices possibly rising as storage and demand pressure increase; pharmaceutical shipments—especially vaccines, insulin, biologics, and cancer therapies—face delays that could raise costs for consumers; and fertilizer flows through the Strait of Hormuz have slowed, heightening farmer costs and the risk of food-price inflation, underscoring that Hormuz is a chokepoint for multiple essential trades beyond energy.

via Business Insider|
#business#fertilizer#helium
Huge recall: nearly 90,000 bottles of children's ibuprofen pulled over foreign material
health22 days ago

Huge recall: nearly 90,000 bottles of children's ibuprofen pulled over foreign material

The FDA announced a recall of about 89,592 bottles of Strides Pharma’s Children’s Ibuprofen Oral Suspension sold in the U.S. after reports of a gel-like mass and black particles. The Class II recall affects lot numbers 7261973A and 7261974A with an expiration date of Jan. 31, 2027, manufactured for Taro Pharmaceuticals USA Inc. and distributed nationwide. No serious adverse health effects have been reported, but consumers should stop using the recalled product immediately.

via WCNC|
#children#fda#health
AI-crafted vaccine for a dog hints at a future where medicine is programmable
markets25 days ago

AI-crafted vaccine for a dog hints at a future where medicine is programmable

A dog named Rose reportedly received a personalized cancer vaccine designed with ChatGPT and Google’s DeepFold and manufactured by a university; while not cured, the cancer was greatly reduced and the dog’s quality of life improved. Tech investor Eric Jackson says this exemplifies “programmable medicine,” where AI-driven genomics and molecule design turn medicine into software, a shift that could boost biotech and AI-enabled stocks such as Moderna (MRNA) and platforms from Nvidia (NVDA), Alphabet (GOOGL), and Microsoft (MSFT), among others. The piece underscores the investment and regulatory implications of moving toward individualized therapies.

via MarketWatch|
#artificial-intelligence#biotechnology#healthcarelife-sciences
Merck reshapes structure to create dedicated cancer unit led by Keytruda
business1 month ago

Merck reshapes structure to create dedicated cancer unit led by Keytruda

Merck will split its human-health business into two units: a cancer-focused division led by Keytruda and a separate non-oncology medicines arm, as the company diversifies ahead of Keytruda’s looming loss of exclusivity. Keytruda remains the world’s top-selling drug, with more than $30 billion in revenue in 2025, accounting for about half of Merck’s total revenue. Shares rose about 1.4% in premarket trading. Merck has expanded its pipeline and made major acquisitions to bolster growth, and appointed Jannie Oosthuizen to lead the new cancer unit.

via CNBC|
#business#cancer#corporate-split
Water-Based Peptide Synthesis Could Cut Waste From Popular GLP-1 Weight-Loss Drugs
science2 months ago

Water-Based Peptide Synthesis Could Cut Waste From Popular GLP-1 Weight-Loss Drugs

The article reports that GLP-1 weight‑loss drugs like Ozempic are produced via solid‑phase peptide synthesis using solvents such as dimethylformamide, generating massive toxic‑chemical waste (estimates exceed 123 million pounds annually for semaglutide alone) and affecting over 80 peptide drugs. A Nature Sustainability study from the University of Melbourne proposes a water‑based synthesis approach—using salts and a biodegradable activating method—to enable high‑concentration peptide production in water, potentially reducing environmental impact if scalable, though industrial rollout remains to be seen.

via Futurism|
#chemistry#environment#health
TrumpRx.gov aims to slash U.S. drug prices via MFN discounts
healthcare2 months ago

TrumpRx.gov aims to slash U.S. drug prices via MFN discounts

President Trump launched TrumpRx.gov to offer steep discounts on 40 high-cost medicines by tying U.S. prices to MFN prices paid in other developed nations. The rollout includes drugs from AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer, with additional products to follow. Patients with prescriptions can access savings via printable or mobile coupons or through manufacturer channels integrated into TrumpRx.gov. Notable examples include large price cuts for diabetes, obesity, fertility, COPD, asthma, and insulin, such as Ozempic, Wegovy, Zepbound, Gonal-F, Cetrotide, Ovidrel, and insulin lispro. The move builds on prior executive orders and agreements aimed at lowering prices and reforming how American drug costs are set.

via The White House (.gov)|
#drug-prices#healthcare#mfn-pricing
GLP-1 Gold Rush: Weight-Loss Jabs Redefine Bodies and the Pharma Race
life-and-arts2 months ago

GLP-1 Gold Rush: Weight-Loss Jabs Redefine Bodies and the Pharma Race

Anjana Ahuja reviews Aimee Donnellan’s Off the Scales, which chronicles the rise of GLP-1 weight-loss injections (Ozempic, Wegovy, Mounjaro) from their science origins to their rapid market dominance, the patent battles and credit disputes, and their sweeping social impact on obesity stigma, healthcare, and industries from food to fashion. The book follows Novo Nordisk’s lead, the competitive push from Eli Lilly, and includes personal-case anecdotes to illustrate life-changing weight loss, while also flagging potential downsides and long-term unknowns as access broadens and patents lapse—remarkably readable but perhaps too broad in scope according to the review.

via Financial Times|
#glp-1#life-and-arts#novo-nordisk
Wegovy shows early momentum with 3,071 U.S. prescriptions in launch days
healthcare-and-pharmaceuticals2 months ago

Wegovy shows early momentum with 3,071 U.S. prescriptions in launch days

Novo Nordisk’s oral Wegovy drew 3,071 U.S. prescriptions in the first four days after its launch, IQVIA data shared by analysts show, indicating early momentum in a competitive weight‑loss market as the company vies with Eli Lilly. The figure counts retail prescriptions only (not online NovoCare Pharmacy fillings), so actual demand is likely higher.

via Reuters|
#health#healthcare-and-pharmaceuticals#novo-nordisk
Patent cliffs spark a new wave of pharma dealmaking
business3 months ago

Patent cliffs spark a new wave of pharma dealmaking

Pharma execs gathering for the JPMorgan healthcare conference expect a robust M&A wave as patent expirations threaten about 12% of industry revenue, with roughly $40bn in sales losing protection this year and about $180bn more going off patent in 2027–28. Big moves are already underway (Merck eyeing Revolution Medicines; Lilly buying Ventyx), and improved pricing-policy clarity under the current administration has lifted deal enthusiasm, pushing the S&P Biotech index to multi-year highs and fueling speculation of even larger consolidations amid a potentially friendlier antitrust environment.

via Financial Times|
#biotech#business#jpmorgan-healthcare-conference
Pink Viagra Returns to the Spotlight
health3 months ago

Pink Viagra Returns to the Spotlight

Addyi, marketed as the 'female Viagra,' was approved over a decade ago amid controversy, but it has proven to be only marginally effective with significant side effects. Despite lobbying efforts and expanded indications for older women, the drug's actual benefits are minimal, with only a slight increase in satisfying sexual events, and it remains a poor choice compared to other medications. The article criticizes the drug's approval process and marketing tactics, emphasizing that it is not a safe or effective solution for female sexual desire issues.

via American Council on Science and Health|
#addyi#drug-efficacy#fda